PROS1 and COVID-19: Demographic characteristics, PSA levels, comorbidities and clinical outcomes of male patients hospitalized at Bozyaka Training and Research Hospital between May 2020 to October 2021 due to COVID-19 and who had PSA measurements within the last one year were retrospectively analyzed.